Skip to main content

Visit or invasion?

It is encouraging to read about vaccines making their way successfully through the early stages of testing. I have been tracking some of the discussion about the SARS-CoV-2 virus in some of the scientific literature. But have to confess that while I can follow the flow of the academic arguments, I find that details ain't sticking in my memory.

I will hardly be alone in having to defer to people with decades of training and experience. However, I have at other stages of my life, seen people benefit from inoculation or vaccination.

More critically, I knew of a family where the parents decided not to allow either of the Salk or Sabin vaccinations against polio to be administered to any of their children. All three caught polio. Although long term there seems to have been no effects, there were many years of misery for the children concerned.

Albert Sabin and Jonas Salk share the glory of all but eradicating polio. But their vaccinations were radically different. Sabin's arrived first to market and was a "dead" virus injected to create immunity. Salk's live-virus oral vaccine shortly followed it.

I think I had the jab. But I certainly remember that a box of sugar cubes became part of the contents of my father's medical bag. Salk's oral vaccine was dripped onto sugar and (almost) every kid took it without question. The small number of dissenters got theirs on a small piece of bread.

I understand that Sabin's jab was considered superior, docs love the needle?, but the ease of administration of a sugar cube won out.

We may be, if we are fortunate, about to see a repeat of the polio vaccine battle. A number of successful vaccines which create the desired antibody creation using a variety of different routes. If successful, that will be good, because a minority for whom a particular vaccine is not appropriate, may have another option.

For the NHS, having a choice of vaccines, if of equal efficacy, should keep the price down as companies compete to get their variant into service.

So for politicians, the challenge will be to avoid dropping options from support when they still look viable. Because in the rush to head off the spread of this virus, the temptation to look for short-cuts is always there.

The traditional "Dr Finlay" approach to community medicine had much to commend it even if a good portion of its success depended on the character of the personal rather than clinical support provided by a trusted local GP. The range of interventions available to them when I was a youngster in the 1940s and 50s was extremely limited by comparison with today.

I remember the excitement of new vaccines and new antibiotics. On one occasion, I had an attack of impetigo, a highly infectious skin condition, which affected my upper lip. This disease killed almost no one and went away of its own accord in about ten days. But I remember my father's excitement at the almost magical effect of Aureomycin, a member of a new class of antibiotics called tetracyclines. Their "trick" was to inhibit the multiplication of bacteria rather than as penicillin which directly attacked them.

As an ointment, it was perfect for my impetigo. It's "magic" effect was, of course, magnified by its using gold as one of its constituents. Hence the "Aureo" prefix. Or so I remember from dinner table discussions. The fact that it was an expensive remedy only seemed to magnify its powers.

Those were simpler days. There wasn't much evidence that GPs spent time extending their skills and knowledge. In today's much more complex world, with a vastly wider range of pharmacological options available, a much greater understanding of the adverse side effects, and the need to consider the interactions of multiple medicines prescribed for more than a single condition in a patient, it's so much more complex.

There was really only one publication that came into the household that gained much consideration. That was MIMS - The Monthly Index of Medical Specialities. It was simply a list of the drugs available for prescription. There were three alphabetical indexes, by drug name, by British Pharmacopoeia name, by disease or condition. And it little bit of commentary at the start about this month's amendments. I suspect this was the only thing father read to keep up to date with what was changing in the medical world. I very rarely saw either the British Medical Journal or the Lancet in his hand. We kids read Pulse, a freebie newspaper for GPs.

MIMS was of some use to the rest of the family too. On a daily basis, packets would be delivered by the postie from drug companies. These samples got slung into a big chest of drawers against the idea that they might prove useful at some future date. Their value seemed to be mostly for self-medication by my siblings and me.

If we thought we were unwell or experiencing a treatable condition, we would consult MIMS. And then rummage around to see if there was a sample that matched our problem. If yes, it was upstairs to consult father. Generally, we would say something like, "Double dose to start and then TID?" (TID - Ter in Die, three times a day - father still prescribed in Latin for names and Greek symbols for quantities). After a brief examination of the medicine, not the patient, he would peer over his specs and generally respond with, "Won't do you any harm".

Today we have central bodies to advise doctors on prescribing. And active monitoring of outcomes.

Choosing from multiple vaccines, as seems not unlikely, will be yet another decision the docs will have to make. But at least there are likely to be solutions available.

I wrote earlier in my diary about our failure to find a vaccine to control the virus clan that causes the common cold even after decades of research. And hung my pessimism about the prospects for a successful SARS-CoV-2 vaccine out to view.

Perhaps today's a day when I should crank up my optimism a notch or two. Although my autumn flu etcetera jabs may require more arms to be punctured in future years. I suspect we shall need at least an annual kick up the rear for our immune systems to continue to be safe from this rotten bug.

As if my cup cannot be already filled up by my pharma-led lifting of mood, my political world will experience a boost today as well.

Boris Johnson is here to help the Independence campaign by reminding us that "London knows best".

Seems he may be visiting the military, as I predicted to my spouse a few days ago, on a visit to Moray.

But then maybe not as he has not done the courtesy of telling the Scottish Government anything about his plans for the day.

Business as usual.

Comments

Popular posts from this blog

Discussions at a Distance

The pace of change seems to be stepping up. This week will see me participate in eleven online video discussions, only one of which is social. Two are international discussions centred around COVID-19 and its potential long-term effects. The remainder are Parliamentary. But I think we have further transitions in our mode of working to make. We shall have legislation to progress. And I am deeply concerned that this key part of our duties excludes those of us unable to be present physically. With social distancing rules also restricting the number who can be present in the Chamber, the scrutiny is potentially reduced while we are accelerating the pace at which we make new, albeit mostly temporary, new laws. The risk of error is rising, although I cannot see any yet. Others may. Two difficulties exist that need our attention. We don't seem to be able to run sessions where some members are physically present while others are "dialled in" from home. And yet even Westmins...

Second-hand politicians

As I was out for my walk yesterday, seven miles since you ask, it struck me that my putting one foot in front of the other was in no way specifically an MSP activity. Indeed if viewed without prior knowledge, and with the sound off, the daily actions other than our appearing in Parliament would look much like other office workers. In a media world, almost any activity can be the subject of a "fly on the wall" series. I watch "Bangers and Cash" which follows the Mathewson family scouring the outhouses of the country for, mostly, immobile old cars which then get sold at their monthly auction in the village hall in Thornton Le-Dale in Yorkshire. Given that my first five or six cars cost no more than a fiver, I am familiar with the task of running transport on a budget as close to zero as you could imagine. The main cost in my early motoring days was simply my time. And generous expenditure on Swarfega hand cleaner. It was a sort of green "gloop" that magi...

Living with error

An interesting week. My first hybrid Committee meeting. I was physically present. Others dialled in by video link. Seemed to work just fine. The legislative machinery of Parliament has now also gone hybrid. I was able to contribute remotely to a couple of the debates on the Agriculture Bill. This was a vital step to ensure that we can continue to support our farmers as the Brexit transition period comes to an end. It provides the foundations upon which we can now start to work with industry and other stakeholders to build a new support mechanism for 2025 and beyond. There was a bit of faffing about during some of the votes. While it was being described as technical problems, it seemed to me to more like human ones. There is one MSP, no names, no pack drill, who just cannot get their mind around anything faintly techie. Given that person's previous professional life, in an area heavily dependent on leading-edge technology, I am beginning to wonder if they just are scunnered at...